Outcome and molecular measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia patients with MEF2D fusions

The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1002/hon.3114. The data underlying this article cannot be shared publicly to protect the confidentiality of individuals that participated in the study, but are available from the corresponding author upon reasonable request. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.